Women's health startup Evvy launches science-backed treatments for vaginal symptom relief

Evvy, a female-founded vaginal microbiome startup, has unveiled new prescription grade, at-home treatments that provide clean, fast-acting vaginal symptom relief. This marks the first time patients can access prescription (Rx) products from Evvy without first taking an Evvy vaginal microbiome test, a significant step forward in their mission to expand access to effective, science-backed women's healthcare.

The new Rx product line includes Pure Boric Acid Suppositories, Hyaluronic Acid Suppositories, Anti-Itch Vulva Cream, and Soothing Vulva Cream - all uniquely formulated by leading OBGYNs and expert vaginal microbiome researchers to address common vaginal health concerns. Patients can order the treatments on Evvy's website, at which point they are matched to an Evvy-affiliated provider who reviews their health information and can prescribe Evvy's Rx products.

To address common symptoms like vaginal pH imbalance, dryness, odor, or irritation, Evvy's at-home treatments are clean, prescription-grade, and non-toxic solutions compounded in a 503a NABP-accredited pharmacy with the highest-quality ingredients. They are designed to alleviate symptoms while users await the comprehensive results of their Evvy Vaginal Health Test.

Kate McLean, Chief Medical Officer, Evvy: "Vaginal discomfort remains a leading reason women and people with vaginas seek medical advice, yet patients lack access to high-quality, effective solutions. Our Vaginal Health Test has already helped tens of thousands of patients pinpoint and treat the root cause of their vaginal symptoms. With this launch, we're expanding access to our science-backed symptom relief treatments to provide a comprehensive approach that delivers both immediate relief and long-term results."

Each product is made with carefully selected, high quality ingredients, and is free from PFAs, parabens, BPAs, phthalates, sulfites, artificial dyes, and fragrances - setting a new standard for clean and effective vaginal healthcare.

While the new treatments offer fast-acting symptom relief, Evvy's Vaginal Health Test remains the most advanced tool for identifying the root cause of vaginal symptoms and guiding patients to the most effective, targeted treatments to rebuild their vaginal microbiome. The Evvy Vaginal Health Test is the world's first and only peer-reviewed, CLIA/CAP/CLEP-certified at-home vaginal microbiome test. It tests for 700+ bacteria and fungi with a single swab (including those related to bacterial vaginosis, yeast infections, UTIs, fertility, and more).

Priyanka Jain, Co-founder and CEO, Evvy: "Our new prescription product line will empower patients to manage their symptoms quickly and confidently while Evvy's advanced testing gets to the root cause of their symptoms. Once patients receive results from our world-leading vaginal microbiome test, we can go beyond symptom relief to deliver personalized care that supports long-term microbiome health for each patient."

Patients who take the Vaginal Health Test also gain access to personalized treatment programs that can include a broader range of Evvy's specialized prescription treatments, including targeted antibiotics, antifungals, vaginal estrogen, and vaginal probiotics — going beyond symptom relief to fight infections and rebuild a healthy vaginal microbiome.

The launch of this prescription product line reflects Evvy's mission to revolutionize vaginal health with science-backed, personalized care - a constant commitment in the face of access to women's healthcare being at risk nationwide. By empowering patients to manage symptoms quickly and effectively, Evvy makes it easier for individuals to discreetly take charge of their health while also providing tools to uncover and address the root causes of symptoms. With advanced testing and treatments tailored to each person's unique microbiome, Evvy is setting a new standard in precision care. Evvy's Vaginal Health Test is available in all 50 states, while Evvy's new treatments are available in 39 states with plans to expand in 2025.

www.evvy.com

Follow Marketing Report on LinkedIn